Quinazoline derivatives as Src tyrosine kinase inhibitors

Details for Australian Patent Application No. 2003278383 (hide)

Owner AstraZeneca AB

Inventors Ple, Patrick

Agent Davies Collison Cave

Pub. Number AU-B-2003278383

PCT Number PCT/GB03/04703

PCT Pub. Number WO2004/041829

Priority 03290900.4 10.04.03 EP; 02292736.2 04.11.02 EP

Filing date 29 October 2003

Wipo publication date 7 June 2004

Acceptance publication date 14 June 2007

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 03290900.4 10.04.03 EP; 02292736.2 04.11.02 EP

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003278383

14 June 2007 Application Accepted

  Published as AU-B-2003278383

11 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278384-A SYSTEM AND METHOD FOR AUTOMATED TRADING

2003278382-PROTECTION SYSTEM